Showing 101 - 110 of 208
Since their introduction in 1993, the structure of physician drug budgets in Germany has changed frequently. Although highly disputed, they have limited the pharmaceutical expenditure of the Statutory Health Insurance Scheme for nearly one decade. This raises the question of how these savings...
Persistent link: https://www.econbiz.de/10013146564
Persistent link: https://www.econbiz.de/10012293581
Persistent link: https://www.econbiz.de/10011688008
Persistent link: https://www.econbiz.de/10012020261
Persistent link: https://www.econbiz.de/10012020376
Persistent link: https://www.econbiz.de/10012424399
Persistent link: https://www.econbiz.de/10012430249
This review is one in a series of analytic efforts designed to inform the policy debate related to health financing. The authors review evidence on health financing arrangements in high income countries as well as reforms over the last 30 years and to identify key policy lessons from this...
Persistent link: https://www.econbiz.de/10012558292
Many OECD countries have undergone reforms over the past decade to introduce advanced roles for nurses in primary care to improve access to care, quality of care and/or to reduce costs. This working paper provides an analysis of these nurse role developments and reforms in 37 OECD and EU...
Persistent link: https://www.econbiz.de/10011822295